Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 49(3): e5011, Mar. 2016. graf
Article Dans Anglais | LILACS | ID: lil-771943

Résumé

There is evidence for participation of peripheral β-adrenoceptors in delayed liquid gastric emptying (GE) induced in rats by dipyrone (Dp), 4-aminoantipyrine (AA), and antipyrine (At). The present study aimed to determine whether β-adrenoceptors are involved in delayed GE induced by phenylpyrazole derivatives and the role of the prevertebral sympathetic nervous system in this condition. Male Wistar rats weighing 220-280 g were used in the study. In the first experiment rats were intravenously pretreated with vehicle (V), atenolol 30 mg/kg (ATE, β1-adrenergic antagonist), or butoxamine 25 mg/kg (BUT, β2-adrenergic antagonist). In the second experiment, rats were pretreated with V or SR59230A 2 mg/kg (SRA, β3-adrenergic antagonist). In the third experiment, rats were subjected to surgical resection of the celiac-superior mesenteric ganglion complex or to sham surgery. The groups were intravenously treated with saline (S), 240 µmol/kg Dp, AA, or At, 15 min after pretreatment with the antagonists or V and nine days after surgery. GE was determined 10 min later by measuring the percentage of gastric retention (%GR) of saline labeled with phenol red 10 min after gavage. The %GR (means±SE, n=6) values indicated that BUT abolished the effect of Dp (BUT+Dp vs V+Dp: 35.0%±5.1% vs 56.4%±2.7%) and At (BUT+At vs V+At: 33.5%±4.7% vs 52.9%±2.6%) on GE, and significantly reduced (P<0.05) the effect of AA (BUT+AA vs V+AA: 48.0%±5.0% vs 65.2%±3.8%). ATE, SRA, and sympathectomy did not modify the effects of treatments. These results suggest that β2-adrenoceptor activation occurred in delayed liquid gastric emptying induced by the phenylpyrazole derivatives dipyrone, 4-aminoantipyrine, and antipyrine. Additionally, the released neurotransmitter did not originate in the celiac-superior mesenteric ganglion complex.


Sujets)
Animaux , Mâle , Antagonistes bêta-adrénergiques/pharmacologie , Anti-inflammatoires non stéroïdiens/pharmacologie , Phénazone/administration et posologie , Gangliectomie , Vidange gastrique/effets des médicaments et des substances chimiques , Récepteurs bêta-adrénergiques/métabolisme , Antagonistes bêta-adrénergiques/administration et posologie , 4-Amino-1,5-diméthyl-2-phényl-1,2-dihydro-3H-pyrazol-3-one/pharmacologie , Aténolol/pharmacologie , Butaxamine/pharmacologie , Métamizole sodique/pharmacologie , Relation dose-effet des médicaments , Ganglions sympathiques/chirurgie , Modèles animaux , Propanolamines/pharmacologie , Rat Wistar , Système nerveux sympathique/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
Détails de la recherche